Berg and Icahn School of Medicine a Mount Sinai Announce R&D Partnership for Drug Discovery and Development
November 17, 2013 at 09:30 pm EST
Share
Berg and the Icahn School of Medicine at Mount Sinai announced a pharmaceutical and diagnostic R&D partnership that will leverage the power of multi-omic biology and data analytics to obtain novel insights and potential therapeutics for cancer, central nervous system and endocrine disorders. Over the course of this five-year partnership, Berg will leverage its award-winning Interrogative Biology(TM) platform in combination with Mount Sinai's expertise in big data, advanced analytics and biological network modeling. Berg and Mount Sinai will adopt an innovative risk and return sharing approach, with downstream royalties significantly higher than the industry standard for academia-pharma partnerships.
Belc Co Ltd is a Japan-based company mainly engaged in the operation of a chain of retail stores in the Tokyo metropolitan area, with a focus on Saitama Prefecture. Its retail stores provide fresh foods, prepared foods, daily necessities and other products. Through its subsidiaries, the Company is engaged in the production and distribution of finished and primary ready-made dishes and other processed products to self-operated stores, as well as the provision of for-sale materials and consumable goods, and the cleaning of stores and related facilities.
BELC CO., LTD. 
